Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report

This case report describes a 44‐year‐old male patient with atopic dermatitis who developed malignant lymphoma (diffuse large B‐cell lymphoma) during the dupilumab treatment.

Guardado en:
Detalles Bibliográficos
Autores principales: Hideaki Uchida, Masahiro Kamata, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Kenjiro Mitsuhashi, Yayoi Tada
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/fb071134a39642af923025fe7e044258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fb071134a39642af923025fe7e044258
record_format dspace
spelling oai:doaj.org-article:fb071134a39642af923025fe7e0442582021-11-08T15:10:53ZDevelopment of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report2574-459310.1002/cia2.12178https://doaj.org/article/fb071134a39642af923025fe7e0442582021-10-01T00:00:00Zhttps://doi.org/10.1002/cia2.12178https://doaj.org/toc/2574-4593This case report describes a 44‐year‐old male patient with atopic dermatitis who developed malignant lymphoma (diffuse large B‐cell lymphoma) during the dupilumab treatment.Hideaki UchidaMasahiro KamataMayumi NagataSaki FukayaKotaro HayashiAtsuko FukuyasuTakamitsu TanakaTakeko IshikawaTakamitsu OhnishiKenjiro MitsuhashiYayoi TadaWileyarticleDermatologyRL1-803Immunologic diseases. AllergyRC581-607ENJournal of Cutaneous Immunology and Allergy, Vol 4, Iss 5, Pp 143-145 (2021)
institution DOAJ
collection DOAJ
language EN
topic Dermatology
RL1-803
Immunologic diseases. Allergy
RC581-607
spellingShingle Dermatology
RL1-803
Immunologic diseases. Allergy
RC581-607
Hideaki Uchida
Masahiro Kamata
Mayumi Nagata
Saki Fukaya
Kotaro Hayashi
Atsuko Fukuyasu
Takamitsu Tanaka
Takeko Ishikawa
Takamitsu Ohnishi
Kenjiro Mitsuhashi
Yayoi Tada
Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
description This case report describes a 44‐year‐old male patient with atopic dermatitis who developed malignant lymphoma (diffuse large B‐cell lymphoma) during the dupilumab treatment.
format article
author Hideaki Uchida
Masahiro Kamata
Mayumi Nagata
Saki Fukaya
Kotaro Hayashi
Atsuko Fukuyasu
Takamitsu Tanaka
Takeko Ishikawa
Takamitsu Ohnishi
Kenjiro Mitsuhashi
Yayoi Tada
author_facet Hideaki Uchida
Masahiro Kamata
Mayumi Nagata
Saki Fukaya
Kotaro Hayashi
Atsuko Fukuyasu
Takamitsu Tanaka
Takeko Ishikawa
Takamitsu Ohnishi
Kenjiro Mitsuhashi
Yayoi Tada
author_sort Hideaki Uchida
title Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
title_short Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
title_full Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
title_fullStr Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
title_full_unstemmed Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
title_sort development of diffuse large b‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: a case report
publisher Wiley
publishDate 2021
url https://doaj.org/article/fb071134a39642af923025fe7e044258
work_keys_str_mv AT hideakiuchida developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT masahirokamata developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT mayuminagata developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT sakifukaya developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT kotarohayashi developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT atsukofukuyasu developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT takamitsutanaka developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT takekoishikawa developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT takamitsuohnishi developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT kenjiromitsuhashi developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
AT yayoitada developmentofdiffuselargebcelllymphomaduringdupilumabtreatmentinapatientwithatopicdermatitisacasereport
_version_ 1718442202579861504